Surgery and post-operative radiotherapy for early stage cervical cancer

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 40, Issue 1, 2000, Pages 66-69

  Vinod, S K ^a,b   MacLeod, C A ^a,b   Dalrymple, C ^a,b   Elliott, P ^a,b   Atkinson, K ^a   Carter, J ^a,b   Firth, I ^a,b  

^a LIVERPOOL HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CYSTIC LYMPHANGIOMA; FEMALE; FEMUR NECK FRACTURE; FISTULA; FOLLOW UP; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 0034066675     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2000.tb03170.x     Document Type: Article

References (20)

1. National Institutes of Health. Consensus Development Conference Statement on Cervical Cancer, 1996.
2. Morrow P. Is pelvic radiation beneficial in the post-operative management of Stage Ib squamous cell cervical carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979 Annual Meeting of The Society of Gynaecologic Oncologists. Gynecol Oncol 1980; 10:105-110.
3. Stockier M, Russell P, McGahan S, Elliott PM, Dalrymple C and Tattersall M. Prognosis and prognostic factors in node-negative cervix cancer. Int J Gynecol Cancer 1996; 6:477-482.
4. Sedlis A, Bundy BN, Rotman M, Lentz SS, Muderspach LI and Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecology Oncology Group Study. Gynecol Oncol 1999; 73:177-183.
5. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 1995; 31:1341-1346.
6. Atkovar G, Uzel O, Ozsahin M et al. Postoperative radiotherapy in carcinoma of the cervix: treatment results and prognostic factors. Radiother Oncol 1995; 35:198-205.
7. Monk BJ, Cha DS, Walker JL et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical cancer. Gynecol Oncol 1994; 54:4-9.
8. Frigerio L, Busci L, Rabaiotti E & Mariani A. Adjunctive radiotherapy after radical hysterectomy in high risk early stage cervical carcinoma. Eur J Gynaecol Oncol 1994; 15:132-137.
9. Soisson AP, Soper JT, Clarke-Pearson DL, Beichuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 1990; 37:390-395.
10. Kinney WK, Alvarez RD, Reid GC et al. Value of adjuvant whole pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol Oncol 1989; 34:258-262.
11. Stock RG, Chen AS, Flickinger JC, Kalnicki S, Seski J. Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 1995; 31:31-36.
12. Blanchi UA, Sartori E, Pecorelli S et al. Treatment of primary invasive cervical cancer. Considerations on 997 consecutive cases Eur J Gynaecol Oncol 1988; 9:47-53.
13. Rotman M, Pajak TF, Choi K et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995; 274:387-393.
14. Haie C, Pejovic MH, Gerbaulet A et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol 1988; 11:101-112.
15. Kridelka FJ, Berg DO, Neuman M et al. Adjuvant small field pelvic radiation for patients with high-risk stage IB lymph node-negative cervical cancer following radical hysterectomy and pelvic lymph node dissection. A pilot study. Cancer 1999:86:2059-2065.
16. Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study. Int J Radiat Oncol Biol Phys 1999; 43:351-358.
17. Tattersall MH, Ramirez C, Coppleson M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 1992; 46:176-181.
18. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. NEnglJMed 1999; 340:1137-1143.
19. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. NEnglJMed 1999; 340:1154-1161.
20. Landoni F, Maneo A, Columbo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib and Ha cervical cancer. Lancet 1997; 350:535-540.